Time intensity curves of Sonazoid in portal vein in the patients with chronic liver disease and in healthy volunteers
-
- Kogita Sachiyo
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Imai Yasuharu
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Seki Yasushi
- Department of Radiology, Ikeda Municipal Hospital
-
- Uto Tomoyuki
- Department of Radiology, Ikeda Municipal Hospital
-
- Iwasaki Tetsuya
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Fukuda Kazuto
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Igura Takumi
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Sawai Yoshiyuki
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Tsuchimoto Yusuke
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Nakamatsu Dai
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Matsumoto Yasushi
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Nakahara Masanori
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Zushi Shinichiro
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Kurokawa Masanori
- Department of Gastroenterology, Ikeda Municipal Hospital
-
- Takamura Manabu
- Department of Radiology, Ikeda Municipal Hospital
Bibliographic Information
- Other Title
-
- Sonazoid造影超音波検査における門脈内Sonazoid停滞時間に関する検討
Search this article
Abstract
Sonazoid, an ultrasonography contrast agent which consists of perflubutane microbubbles with shells, is stable in blood vessels and remains for a long time. We investigated time intensity curves of Sonazoid in portal vein in the patients with chronic liver disease and healthy volunteers. Among 25 patients with chronic liver disease, Sonazoid remained at the rates of 54.8±15.2%, 32.5±13.3%, 25.2±12.2%, 8.8±7.1% in the portal vein, 10, 20, 30, and 60 minutes after injection, respectively. In healthy volunteers, Sonazoid remained at the rates of 60.1±12.9%, 41.4±11.4%, 32.0±10.3%, 7.8±4.5% in the portal vein, 10, 20, 30, and 60 minutes after injection, respectively. It is recommended that Kupffer images of Sonazoid-enhanced contrast ultrasonography is evaluated 60 minutes after injection of Sonazoid to avoid an influence of sonazoid remaining in the vessels.<br>
Journal
-
- Kanzo
-
Kanzo 50 (10), 593-594, 2009
The Japan Society of Hepatology
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679769631360
-
- NII Article ID
- 10026100660
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed